Announced details
1.35 million teleradiology procedures annually. The Grand HIMEDIC Club has approximately 36,000 members.
株式会社ハイメディック, iMedical, and 株式会社セントメディカル・アソシエイツ are group companies of the Company. From 30 September 2026, iMedical will be a direct subsidiary of 株式会社ハイメディック. iMedical and MITSUI & CO.,LTD. will continue their joint venture relationship. 株式会社ハイメディック holds a 33.8% stake in 京都プロメド株式会社.
株式会社ハイメディック is headquartered in Shibuya, Tokyo. Its representative director and president is Fushimi Yuki (伏見 有貴), and its representative director is Furukawa Tetsuya (古川 哲也). Established in September 1992, it operates a membership-based comprehensive medical club. 株式会社iMedical is headquartered in Chiyoda, Tokyo, was established in June 2013, and provides teleradiology support services and related services. 株式会社セントメディカル・アソシエイツ is headquartered in Nagoya, Aichi, was established in November 2006, and provides teleradiology support services. 京都プロメド株式会社 is an affiliated company of Kyoto University. MITSUI & CO.,LTD. is iMedical's joint venture partner and oversees its ICT Business Unit.
Shibuya, Tokyo, Chiyoda-ku, Tokyo, Nagoya, Aichi Prefecture, Tokyo, Yokohama, Nagoya, Kyoto, and Osaka
The Company aims to enhance corporate value over the medium to long term, but no specific amount of the impact on results from this matter is stated.
The company does not address Contract Value / Offering price.
| Item | Details |
|---|---|
| Names of Products / Services Covered | Grand HIMEDIC Club, Teleradiology support services, Diagnostic imaging services using AI-assisted image interpretation |
| Counterparty | 株式会社ハイメディック, 株式会社iMedical, 株式会社セントメディカル・アソシエイツ, 京都プロメド株式会社, MITSUI & CO.,LTD. |
| Counterparty overview | 株式会社ハイメディック is headquartered in Shibuya, Tokyo. Its representative director and president is Fushimi Yuki (伏見 有貴), and its representative director is Furukawa Tetsuya (古川 哲也). Established in September 1992, it operates a membership-based comprehensive medical club. 株式会社iMedical is headquartered in Chiyoda, Tokyo, was established in June 2013, and provides teleradiology support services and related services. 株式会社セントメディカル・アソシエイツ is headquartered in Nagoya, Aichi, was established in November 2006, and provides teleradiology support services. 京都プロメド株式会社 is an affiliated company of Kyoto University. MITSUI & CO.,LTD. is iMedical's joint venture partner and oversees its ICT Business Unit. |
| Relationship with the Company | 株式会社ハイメディック, iMedical, and 株式会社セントメディカル・アソシエイツ are group companies of the Company. From 30 September 2026, iMedical will be a direct subsidiary of 株式会社ハイメディック. iMedical and MITSUI & CO.,LTD. will continue their joint venture relationship. 株式会社ハイメディック holds a 33.8% stake in 京都プロメド株式会社. |
| Launch date | 30 September 2026 (planned; change in oversight of iMedical) |
| Applicable area | Diagnostic imaging, Teleradiology, Health screening and preventive healthcare, Medical ICT, Healthcare and nursing care operations |
| Location | Shibuya, Tokyo, Chiyoda-ku, Tokyo, Nagoya, Aichi Prefecture, Tokyo, Yokohama, Nagoya, Kyoto, and Osaka |
| Location scale | 株式会社ハイメディック has 14 locations nationwide and approximately 36,000 members. 株式会社セントメディカル・アソシエイツ has more than 60 contracted medical institutions. |
| Usage history | 1.35 million teleradiology procedures annually. The Grand HIMEDIC Club has approximately 36,000 members. |
| Impact on Business Performance | The Company aims to enhance corporate value over the medium to long term, but no specific amount of the impact on results from this matter is stated. |
Items this document does not state (8)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The initiative aims to strengthen the diagnostic imaging and teleradiology businesses, operate 株式会社ハイメディック's health screening and preventive healthcare services together with iMedical's teleradiology support services, improve diagnostic imaging quality, secure a stable supply of specialist resources, enhance medical ICT services through technologies such as AI-assisted image interpretation, and create new value.